Dr. Argula is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
171 Ashley Ave
Charleston, SC 29425Phone+1 843-792-1414Fax+1 843-953-8709
Summary
- I am board certified in Internal Medicine, Pulmonary Disease and Critical Care Medicine. I completed my medical schooling at JIPMER in India and moved to the US in 2005. I graduated from the University of Texas School of Public health with an MPH degree. I went on to complete a residency in internal medicine, followed by a fellowship in Pulmonary and Critical Care Medicine, also at MUSC. I joined the Division of Pulmonary, Critical Care, Allergy and Sleep Medicine as an Assistant Professor in July 2013.
My clinical interests are in the areas of Pulmonary Vascular Disease, Pulmonary Hypertension, Advanced COPD and Interstitial Lung Disease.
My research interests are to develop novel imaging based biomarkers to diagnose and monitor pulmonary vascular diseases like pulmonary hypertension.
Education & Training
- Medical University of South CarolinaFellowship, Pulmonary Disease and Critical Care Medicine, 2010 - 2013
- Medical University of South CarolinaResidency, Internal Medicine, 2007 - 2010
- University of Texas Health Science Center, School of Public Health (UTHSC)M.P.H., 2005 - 2008
- University of Texas Health Science Center, School of Public HealthMPH, Epidemiology & Biostatistics, 2005 - 2007
- Jawaharlal Institute of Postgraduate Medical Education and ResearchClass of 2005
Certifications & Licensure
- SC State Medical License 2011 - 2025
- PA State Medical License 2013 - 2013
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- 1st Prize, Oral Presentation 2012
- 1st Prize, Oral Presentation Society of Critical Care Medicine, 2010
- 2nd Prize, Poster Presentation SC Regional American College of Physicians (ACP), 2009
- Join now to see all
Clinical Trials
- Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH) Start of enrollment: 2011 Jun 24
- Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension RANGER Start of enrollment: 2017 Apr 18
Publications & Presentations
PubMed
- Inhaled Nitric Oxide in Fibrotic Lung Disease: A Randomized, Double-Blind, Placebo-controlled Trial.Steven D Nathan, Natasa Rajicic, Rosemarie Dudenhofer, Rahat Hussain, Rahul Argula
Annals of the American Thoracic Society. 2024-12-01 - Association of Cardiopulmonary Hemodynamics and Outcomes in Pulmonary Hypertension Following Kidney Transplantation: A Multicenter Retrospective Cohort Study.Arun Jose, Sathish S Kumar, Leonid Gorelik, Samuel H Friedman, Antolin S Flores
Chest. 2024-12-01 - Treatment with Oral or Inhaled Treprostinil in Patients with Pulmonary Arterial Hypertension and Cardiovascular Comorbidities.R James White, Karim El-Kersh, Stephan Rosenkranz, Veronica Franco, Carmine Dario Vizza
Chest. 2024-11-30
Authored Content
- A Case Series and Systematic Review of Urinothorax☆April 2017
Professional Memberships
- Member
- Member
Other Languages
- Tamil, Hindi, Telugu, Urdu
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: